BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights: Strategic Trials and ... [Yahoo! Finance]
BioXcel Therapeutics, Inc. (BTAI)
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Net Revenue for Nine Months Ended September 30, 2024: $1.9 million, an 89% increase from $1 million in the same period in 2023. Cost of Goods Sold: $1.2 million for Q3 2024, compared to $512,000 for Q3 2023. Research and Development Expenses: $5.1 million for Q3 2024, compared to $19.6 million for Q3 2023. Selling, General, and Administrative Expenses: $7.7 million for Q3 2024, compared to $24.3 million for Q3 2023. Net Loss: $13.7 million for Q3 2024, compared to $50.5 million for Q3 2023. Operating Cash Used: $16.3 million during Q3 2024. Cash and Cash Equivalents: $40.4 million as of September 30, 2024. Warning! GuruFocus has detected 6 Warning Signs with BTAI. Release Date: November 14, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript BioXcel Therapeutics Inc ( NASDAQ:BTAI ) announced important milestones with two pivotal Phase 3 trials for BXCL501, targeting agitation associated with bipolar disorder, sc
Show less
Read more
Impact Snapshot
Event Time:
BTAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BTAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BTAI alerts
High impacting BioXcel Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
BTAI
News
- BioXcel Therapeutics (BTAI) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]Yahoo! Finance
- BioXcel Therapeutics Announces Pricing of $7.0 Million Public OfferingGlobeNewswire
- BioXcel Therapeutics Announces Proposed Public OfferingGlobeNewswire
- BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- BioXcel Therapeutics Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
BTAI
Earnings
- 11/14/24 - Beat
BTAI
Sec Filings
- 12/18/24 - Form SCHEDULE
- 12/18/24 - Form SCHEDULE
- 12/18/24 - Form PRE
- BTAI's page on the SEC website